Form 8-K - Current report:
SEC Accession No. 0001193125-25-126273
Filing Date
2025-05-27
Accepted
2025-05-27 08:13:24
Documents
14
Period of Report
2025-05-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d845572d8k.htm   iXBRL 8-K 23852
2 EX-99.1 d845572dex991.htm EX-99.1 11488
6 GRAPHIC g845572g0527021420379.jpg GRAPHIC 5005
  Complete submission text file 0001193125-25-126273.txt   161687

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA svra-20250527.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20250527_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20250527_pre.xml EX-101.PRE 11272
17 EXTRACTED XBRL INSTANCE DOCUMENT d845572d8k_htm.xml XML 3714
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 25984364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)